IP – Page 4 – Pharma.Tips

Excipient incompatibility with API during scale-up – preventing late-stage reformulation

Understanding and Investigating Excipient Incompatibility with API During Scale-Up In the realm of pharmaceutical manufacturing, the transition from laboratory-scale production to full-scale commercial output can surface significant challenges, particularly concerning…

Functional performance failure during formulation development – compatibility study expectations

Investigating Functional Performance Failures During Formulation Development: Addressing Compatibility Study Expectations Functional performance failures during formulation development can disrupt production and lead to significant quality concerns. These failures often manifest…

Moisture sensitivity overlooked during stability assessment – compatibility study expectations

Investigating Overlooked Moisture Sensitivity in Stability Assessments for Pharma Products In the pharmaceutical industry, ensuring the stability and compatibility of raw materials, especially excipients, is crucial. However, moisture sensitivity is…

Excipient incompatibility with API during supplier qualification – preventing late-stage reformulation

Addressing Excipient Incompatibility with APIs During Supplier Qualification Excipient incompatibility with active pharmaceutical ingredients (APIs) during supplier qualification can lead to significant challenges, including increased costs and delays in product…

Moisture sensitivity overlooked during formulation development – CAPA for formulation failures

Understanding the Risks of Overlooking Moisture Sensitivity During Formulation Development In the pharmaceutical industry, overlooking moisture sensitivity during formulation development can lead to significant deviations, compromised active pharmaceutical ingredient (API)…

Functional performance failure during formulation development – risk assessment for excipient choice

Assessing Functional Performance Failures in Formulation Development through Excipient Risk Evaluation In pharmaceutical manufacturing, functional performance failures during formulation development can severely compromise product quality and regulatory compliance. Understanding how…

Functional performance failure during scale-up – risk assessment for excipient choice

Assessing Functional Performance Failures During Scale-Up: An Investigative Approach Functional performance failures during scale-up can present significant challenges in pharmaceutical manufacturing, particularly concerning excipient selection and compatibility. Such failures can…

Functional performance failure during regulatory review – regulatory scrutiny of excipient data

Investigating Functional Performance Failures During Regulatory Review of Excipient Data Functional performance failures during regulatory review can lead to scrutiny over excipient data, impacting your manufacturing processes and compliance standing.…

Supplier grade substitution during supplier qualification – risk assessment for excipient choice

Assessing the Risks of Supplier Grade Substitution in Excipient Selection In the pharmaceutical industry, the selection of excipients plays a critical role in ensuring the quality and efficacy of final…

Variability in excipient grade during supplier qualification – compatibility study expectations

Understanding Variability in Excipient Grade During Supplier Qualification: A Comprehensive Investigation In the pharmaceutical industry, variability in excipient grade during supplier qualification can lead to significant impacts on product quality…

Moisture sensitivity overlooked during regulatory review – compatibility study expectations

Overlooked Moisture Sensitivity During Regulatory Reviews: Ensuring Compatibility Studies Meet Expectations The pharmaceutical industry operates under stringent regulations where the integrity of raw materials, particularly excipients and active pharmaceutical ingredients…

Supplier grade substitution during formulation development – compatibility study expectations

Examining Supplier Grade Substitution During Formulation Development: Expectations for Compatibility Studies In the pharmaceutical landscape, the substitution of excipients or active pharmaceutical ingredients (APIs) during formulation development presents a complex…